New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a
NFH.WS
NFH.WS was delisted on the 26th of January, 2022.
21 hedge funds and large institutions have $10.2M invested in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in 2019 Q4 according to their latest regulatory filings, with 21 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$2.63M |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$1.12M |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$635K |
| 4 |
MTCM
Mint Tower Capital Management
Amsterdam,
Netherlands
|
+$423K |
| 5 |
GCL
Glazer Capital LLC
New York
|
+$336K |
Top Sellers
NFH.WS Hedge Fund Activity: Q4 2019 in Review
21 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) for Q4 2019, worth a combined $10.2M.
Buyers outnumbered sellers: 21 funds opened new NFH.WS positions and 0 closed out — a net gain of 21 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was BlueCrest Capital Management, opening a new position worth an estimated $2.63M.
- 21 institutional investors held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) as of Q4 2019, up from 0 in Q3 2019.
- Funds reported $10.2M of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a stock for Q4 2019.
- 21 funds opened new New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a positions in Q4 2019 and 0 closed out, a net change of +21 holders.
- The largest New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a buyer in Q4 2019 was BlueCrest Capital Management, an estimated $2.63M added.
Based on aggregated 13F filings for Q4 2019.